www.fdanews.com/articles/87303-glenmark-ties-up-with-paul-capital-of-usa-to-develop-dermatology-products
GLENMARK TIES UP WITH PAUL CAPITAL OF USA TO DEVELOP DERMATOLOGY PRODUCTS
June 5, 2006
Glenmark Pharmaceuticals Inc (GPI), a wholly owned US subsidiary of Glenmark Pharmaceuticals, has announced a royalty deal with Paul Capital Partners Royalty fund, an international healthcare investment fund to develop generic prodcuts in the dermatology portfolio for the billion dollar US markets.